This pattern suggests that if hair loss occurs during GLP-1 treatment, it likely results from physiological stress or nutritional factors rather than direct drug toxicity to hair follicles
Post hoc analysis of SURPASS-CVOT trial has implications for future cardiovascular outcome trials Image content: This image is available to view online
INCI: Aqua (Water), Propanediol, Niacinamide, Glycerin, Trehalose, Panthenol, Phenoxyethanol, Ethylhexylglycerin, BetaGlucan, Allantoin, Copper Tripeptide1, Hydroxyethylcellulose, Sodium Hyaluronate, Lactic Acid, Sodium Hydroxide
GLP-1 for Perimenopause Weight Loss: UK Guide Perimenopause brings hormonal fluctuations that can make weight management particularly challenging, with many women experiencing shifts in fat distribution and metabolic changes